Xilio Therapeutics, Inc.
XLOPharmaceutical Preparations · SIC 2834 · CIK 0001840233
Revenue FY2025
$44.0M
Net Income
$(35.0M)
EPS (Basic)
$-4.19
Net Margin
-80.1%
ROE
-99.3%
Total Equity
$35.0M
Shares Out
6M
Xilio Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 2 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
OrbiMed Advisors
OrbiMed Advisors
$5.7M
0.0%
NEW
Adage Capital Management
Adage Capital Management
$1.1M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…